Start Date
January 31, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2010
fondaparinux
fondaparinux subcutaneous injection once daily until INR stable in therapeutic range, at least five days: 5 mg if less than 50 kg, 7.5 mg if 50-100 kg, 10 mg if \>100 kg
argatroban or lepirudin
continuous infusion titrated into therapeutic range and for at least 5 days and until INR stable in therapeutic range
Lead Sponsor
University of Tennessee
OTHER
Methodist Healthcare
OTHER